Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vertex

Is a new painkiller too good to be true?

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids

Salon

FDA approves new type of non-opioid pain medication in two decades

The new drug will be many times more expensive than a standard opioid option

The Independent UK

£1.65m gene-editing therapy offers hope of cure for some blood disorder patients

The treatment uses gene-editing tool Crispr, which earned its inventors the Nobel Prize in chemistry in 2020.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA approves new painkiller that shows promise and challenges of opioid alternatives

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids

The Independent UK

Vertex's Pain Drug: Big Pharma's Next Major Success?

Vertex Pharmaceuticals' innovative pain drug holds significant potential, positioning the company for substantial growth in the expanding market.

MarketBeat

Vertex Pharmaceuticals Earnings Preview: What to Expect

With Vertex Pharmaceuticals gearing up to release its fourth-quarter earnings next month, analysts predict a single-digit drop in profit.

Barchart

20 innovative breakthroughs that will transform your health

We recognize some of the most staggering, game-changing, life-improving developments of the year.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Decoding 9 Analyst Evaluations For Vertex

During the last three months, 9 analysts shared their evaluations of Vertex (NASDAQ:VERX), revealing diverse outlooks from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

Benzinga

Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart

Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?

Vertex Pharmaceuticals has outperformed the Nasdaq over the past year, and analysts remain moderately bullish about the stock's prospects.

Barchart

Are Wall Street Analysts Bullish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market in 2024 but Wall Street analysts remain cautiously bullish about the stock's potential.

Barchart

The British watch brands to know now: from intriguing innovators to heritage revivals

British watch brands are in the ascendant – discover some of the most exciting names and their timepieces

Wallpaper

Is Vertex Stock Outperforming the S&P 500?

Vertex has outperformed the S&P 500 over the past year, and analysts are moderately bullish on the stock.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Creative Bloq

Vertex 2024 - our best bits and some surprises

We had a blast at Vertex 2024, here are the highlights.

Advnture

Arc’teryx Vertex Alpine GTX approach shoe review: style and performance on above-the-treeline adventures

The close-fitting Arc’teryx Vertex Alpine GTX approach shoe offers reassuring rigidity, protection and grip for battles against gravity

Creative Bloq

Don't miss the chance to get pro tips from ILM concept artist Bimpe Alliu

Improve your portfolio with personalised one-on-one advice.

Guitar World

“It’s not the world’s greatest solo, but we spent hours on it”: Session legend Dann Huff recalls recording with Michael Jackson and Shania Twain – and begging Michael Bolton to let him play a solo with a Peavey acoustic

Huff recounts his session contributions during a new in-depth interview – and explains how his heavily-modded ‘64 Strat “cut through the synthesizers of the ‘80s” and put him in great demand

Get all your
news in one place.

100’s of premium titles.
One news app.

Creative Bloq

Vertex flash sale: save £30 on a ticket to our digital art and 3D festival - speakers include Pernille Ørum, Pixar's Dylan Sisson and David Levy

Learn from industry pros, and save money.

Creative Bloq

Vertex 2024: Annie Clare on how to craft the perfect team for a video games studio

Lighthouse Games' head of people will discuss practical approaches to building teams and unlocking creative potential.

Creative Bloq

Vertex 2024: gain inspiration from artist and director Andy Poyiadgi

The comic book artist and creative lead shares his influences ahead of the event.

Creative Bloq

Vertex 2024: see how HaZ Dulull blurs the line between film and video games in Unreal Engine

The producer, director and HaZimation co-founder will discuss his transmedia approach to producing IP in movies and games.

Creative Bloq

Find your tribe at Vertex

Join us to connect and learn at the ultimate festival of digital art, animation and VFX.

Creative Bloq

Vertex 2024 speaker: learn insights from Dolph Souza's 3D workflow

The animator and director will share some of his process at this year's event.

Creative Bloq

Vertex 2024: learn how to build worlds in concept art with Anna Hollinrake

The award-winning art director will share tips on how to confront a blank sheet of paper.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.